葡萄糖管理指标在非白人糖尿病患者中评估血糖控制的价值
该回顾性研究分析了316例糖尿病患者(非白人68例,白人248例)的持续葡萄糖监测指标,发现两组葡萄糖管理指标(GMI)无差异,但非白人组HbA1c更高(8.7% vs. 8.1%,P=0.004)。非白人组中HbA1c高于GMI≥0.5%更常见(90% vs. 75%,P=0.02),且仅在该组中此差异与低血糖持续时间更长相关。
要点
- 非白人糖尿病患者HbA1c高于GMI≥0.5%的比例显著高于白人(90% vs. 75%)。
- 非白人组HbA1c高于GMI≥0.5%者低血糖持续时间更长。
- 解读非白人患者GMI与HbA1c差异时需警惕低血糖风险。
核心结论
- 非白人与白人糖尿病患者中HbA1c与GMI的关系存在差异。
- 非白人患者中HbA1c与GMI差异较大与低血糖风险更高相关。
研究设计与样本
- 回顾性分析持续葡萄糖监测指标,按种族分为非白人组(n=68)和白人组(n=248),共316例糖尿病患者。
主要发现
- 两组GMI无显著差异(7.6 vs. 7.7;P无显著性)。
- 非白人组HbA1c高于白人组(8.7% vs. 8.1%;P=0.004)。
- 非白人组HbA1c高于GMI≥0.5%的比例更高(90% vs. 75%;P=0.02)。
- 仅在非白人组中,HbA1c高于GMI≥0.5%者的低血糖持续时间长于HbA1c与GMI差异在0.5%以内者。
临床怎么用
- 临床解读非白人糖尿病患者GMI与HbA1c不一致时,应关注低血糖风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the relationship between the glucose management indicator (GMI) and HbA1c in non-White individuals with diabetes. RESEARCH DESIGN AND METHODS: We performed a retrospective analysis of continuous glucose monitoring metrics in individuals with diabetes divided by race into non-White and White cohorts. RESULTS: We evaluated 316 individuals (non-White n = 68; White n = 248). Although GMI was not different (7.6 vs. 7.7; P = not significant) between the cohorts, HbA1c was higher in the non-White cohort (8.7% vs. 8.1%; P = 0.004). HbA1c higher than GMI by ≥0.5% was more frequently observed in the non-White cohort (90% vs. 75%; P = 0.02). In the non-White cohort only, duration of hypoglycemia was longer among those with HbA1c higher than GMI by ≥0.5% compared with those with HbA1c and GMI within 0.5%. CONCLUSIONS: A differential relationship between HbA1c and GMI in non-White versus White individuals with diabetes was observed. In non-White individuals, a greater difference between HbA1c and GMI was associated with higher risk of hypoglycemia.
引用
- Toschi E, Michals A, Adam A, et al. Usefulness of CGM-Derived Metric, the Glucose Management Indicator, to Assess Glycemic Control in Non-White Individuals With Diabetes. Diabetes Care. 2021. PMID: 34635503. doi:10.2337/dc21-1373
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。